Asthma Clinical Research Studies

Treatment options for asthma continue to evolve. Currently, our center has multiple asthma studies for treatments that include: investigational inhalers for children, generic versions of already marketed medication, oral medications as add-on therapy, injections as add-on therapy, and biologics (complicated molecules that are manufactured within a living organism). Each of these asthma studies offer unique treatment opportunities for patients with mild to extremely severe asthma. These medications are provided at absolutely no cost, with no insurance needed. You may also be reimbursed for your time and travel and will receive care from physicians affiliated with the Clinical Research Center of Alabama.
For more information on any of the following asthma studies, please contact Will O’Donnell by calling 205.209.4179 or emailing [email protected]

Observational Study

Age 19+

Chronicle

The purpose of this study is to collect information to help us understand how doctors treat and manage people with severe asthma and how the health of people with severe asthma changes with those treatments. In this study, no specific treatment or research drug is given, but your normal care and assessments are recorded. The length of each patient’s participation will vary but the goal is to have patients involved for 3 or more years.

Biologic Injection Study

Age 19+

TEVA 20033

The purpose of this research study is to learn about the effects of the investigational study drug called TEV-53275 on asthma and quality of life when compared to placebo for those with asthma called “eosinophilic asthma” (associated with a high count of white blood cells called eosinophils), that is persistent and moderate to severe. The study will also look at how safe and well tolerated the study drug is when added to your regular asthma medications.

BIOLOGIC FOR ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS-ABPA

Age 12+

REGENERON1923
The main purpose of this study is to determine if dupilumab is effective and safe in decreasing episodes of severe breathing difficulties that you may have.

Investigational Biologic Inhaler Study

Age 19-75

NovartisCSJ
The purpose of the study is to see if the inhaled investigational study medication (CSJ117) works better than placebo in improving your lung function and if there are side effects of CSJ117, how serious they are, and how many times they happen compared with placebo.

Become a Participant in our Asthma Studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.